NASDAQ: SBFMSunshine Biopharma Inc Stock Ownership - Who owns Sunshine Biopharma?
Insider buying vs selling
Have Sunshine Biopharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Steve N. Slilaty | Chief Executive Officer | 2024-03-04 | 100,000 | $0.10 | $10.00kBuy |
| Steve N. Slilaty | Chief Executive Officer | 2024-02-08 | 20,000 | $0.10 | $2.00kBuy |
SBFM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SBFM insiders and whales buy or sell their stock.
SBFM Shareholders
What type of owners hold Sunshine Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Malek Chamoun | 3.72% | 3,700,000 | $251.60k | Insider |
| Armistice Capital LLC | 2.14% | 2,130,000 | $144.84k | Institution |
| Bridgeway Capital Management LLC | 0.29% | 286,100 | $19.45k | Institution |
| Citadel Advisors LLC | 0.19% | 185,255 | $12.60k | Institution |
| Camille Sebaaly | 0.18% | 174,465 | $11.86k | Insider |
| Steve N. Slilaty | 0.13% | 130,000 | $8.84k | Insider |
| Renaissance Technologies LLC | 0.07% | 66,600 | $4.53k | Institution |
| Virtu Financial LLC | 0.02% | 23,862 | $1.62k | Institution |
| Geode Capital Management LLC | 0.02% | 20,179 | $1.37k | Institution |
| Xtx Topco Ltd | 0.02% | 17,495 | $1.19k | Institution |
SBFM vs Pharmaceutical Stocks
Sunshine Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.